Ask AI
ProCE Banner Activity

Precision in Practice: Navigating AE Mitigation in the Era of Targeted Treatments to Elevate Clinical Outcomes for Patients With High-Risk HR+/HER2- Breast Cancer

Slideset

Download these slides to enhance your approach to managing adverse events associated with targeted therapies for high-risk HR-positive/HER2-negative breast cancer. Explore practical strategies to individualize treatment and optimize patient outcomes.

Released: April 17, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Target Audience

This activity is intended for nurse practitioners, physician associates, clinical nurse specialists, advanced-degree nurses, and other healthcare professionals who care for patients with breast cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement evidence-based strategies to proactively identify, prevent, and manage adverse events associated with CDK4/6 inhibitors, oral SERDs, and PI3K/AKT-targeted therapies for patients with high-risk HR-positive/HER2-negative breast cancer in both adjuvant and metastatic settings

  • Individualize targeted therapy regimens based on patient- and disease-specific variables to optimize treatment outcomes for patients with high-risk HR-positive/HER2-negative breast cancer

  • Apply enhanced patient communication and shared decision-making skills in educating, monitoring, and supporting patients receiving targeted therapies to improve adherence and clinical outcomes